EGFR and lung carcinoma: For example, in lung cancer, E2 upregulated the expression of osteopontin (OPN), which contributes to the cross-talk between the ER and EGFR signaling pathways and estrogen-promoted cell migration through activating ERβ of the MEK/ERK signaling pathway (62).